NCT05198986

Brief Summary

The Acute Respiratory Distress Syndrome (ARDS) is defined by a recent (within 1 week) respiratory failure, not fully explained by cardiac failure or fluid overload. ARDS is also characterized by bilateral opacities at the chest imaging, with an alteration of the oxygenation while positive end-expiratory pressure equal or greater than 5 cmH2O is applied. Severe ARDS is characterized by a high mortality. In the most severe ARDS patients, venovenous extracorporeal membrane oxygenation (vv-ECMO) is increasingly accepted as a mean to support vital function, although not free from complications. In patients with severe ARDS, prone position has been used for many years to improve oxygenation. In these patients, early application of prolonged (16 hours) prone-positioning sessions significantly decreased 28-day and 90-day mortality. More recently, prone position and ECMO have been coupled as concurrent treatment. Indeed, the addition of prone positioning therapy concurrently with ECMO can aid in optimizing alveolar recruitment, and reducing ventilator-induced lung injury. Nowadays, few data exist on respiratory mechanics modifications before and after the application of prone position in patients with severe ARDS receiving vv-ECMO. The investigators have therefore designed this observational study to assess the modifications of mechanical properties of the respiratory system, ventilation and aeration distribution, and hemodynamics occurring during ECMO before and after prone position in patients with severe ARDS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

January 20, 2022

Completed
12 days until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2023

Completed
Last Updated

January 20, 2022

Status Verified

January 1, 2022

Enrollment Period

1.1 years

First QC Date

January 3, 2022

Last Update Submit

January 14, 2022

Conditions

Keywords

Extra Corporeal Membrane OxygenationProne Position

Outcome Measures

Primary Outcomes (1)

  • Driving Pressure

    Difference between the airway plateau pressure and the total positive end-expiratory pressure after an inspiratory and expiratory hold maneuvers, respectively

    30 minutes after the prone positioning

Secondary Outcomes (4)

  • Respiratory system compliance

    30 minutes after the prone positioning

  • Cardiac output

    30 minutes after the prone positioning

  • Pulmonary arterial pressure

    30 minutes after the prone positioning

  • End-Expiratory Lung Impedance

    30 minutes after the prone positioning

Study Arms (1)

ECMO Prone Position

After baseline assessment in supine position, patients will be positioned in prone position to assess modification of lung mechanics, aeration and hemodynamics

Other: Prone Position during Extra Corporeal Membrane Oxygenation (ECMO)

Interventions

Pronation will be executed according to a predefined protocol: 4 caregivers will be required for the procedure, one of them being dedicated to the management of the head of the patient, the endotracheal tube and the ventilator lines. The others will stand at each side of the bed. In the first step, the direction of the rotation will be decided giving priority to the side of the central venous lines. The patient will be then moved along the horizontal plane to the opposite side of the bed selected for the direction of rotation. In the third step, the patient will be moved in the sagittal plane and maintained in that position for a short while to attach the cardiac electrodes to her/his back and to set a new bed sheet. In the last step, the patient will be turned to the complete prone position.

ECMO Prone Position

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients will receive deep sedation and continuous infusion of neuromuscular blocking agents. Protective mechanical ventilation will be set in volume-controlled mode. A pulmonary artery catheter (PAC) will be also positioned and connected to a dedicated system for hemodynamic monitoring. After enrolment, a silicon 16-electrode belt of proper size will be positioned around the patient's chest between the 4th and 6th intercostal spaces and connected to the EIT device. The position of EIT belt will be therefore marked on the skin with a dermographic pencil to avoid its displacement. Invasive mechanical ventilation will be applied with a ventilator connected to the EIT device through a RS232 interface.

You may qualify if:

  • all adult patients with a diagnosis of severe Acute Respiratory Distress Syndrome receiving veno-venous ECMO

You may not qualify if:

  • mechanical ventilation for 7 days or longer
  • pregnancy
  • body mass index (BMI) \> 45 kg/m2
  • chronic respiratory failure with long-term oxygen therapy or domiciliary non-invasive ventilation
  • cardiac failure resulting in veno-arterial ECMO
  • history of heparin- induced thrombocytopenia
  • cancer with a life expectancy of less than 5 years
  • moribund condition or a Simplified Acute Physiology Score (SAPS-II) value of more than 90;
  • current non drug- induced coma after cardiac arrest or presence of an irreversible neurologic injury
  • decision to withhold or withdraw life--sustaining therapies
  • presence of pneumothorax and/or pulmonary emphysema
  • recent (1 week) thoracic surgery
  • presence of chest burns
  • refusal of consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Federico Longhini

Catanzaro, 88100, Italy

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Federico Longhini, MD

    Magna graecia University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Federico Longhini, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

January 3, 2022

First Posted

January 20, 2022

Study Start

February 1, 2022

Primary Completion

February 28, 2023

Study Completion

February 28, 2023

Last Updated

January 20, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will share

Deindividualized data will be share on reasonable request to the Principal Investigator after study completion and publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available after study completion and publication
Access Criteria
On reasonable request

Locations